| CONTENTS |
|
|
|
Clinical
Investigations
Active
surveillance
Recurrent
prostate cancer
Localized
prostate cancer
|
|
|
CLINICAL INVESTIGATIONS
|
|
|
Cholesterol |
|
Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.
Use
of statins and prostate cancer recurrence among patients treated with
radical prostatectomy.
BJU Int. 2013 May;111(6):954-62.
doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.
Abstract
| Related
citations
|
|
Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.
Statins
and prostate cancer recurrence following radical prostatectomy or
radiotherapy: a systematic review and meta-analysis.
Ann
Oncol. 2013 Mar 18. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
Functional
outcomes |
|
Ficarra V, Borghesi M, Suardi N, De Naeyer G, Novara G, Schatteman P, De
Groote R, Carpentier P, Mottrie A.
Long-term
evaluation of survival, continence and potency (SCP) outcomes after
robot-assisted radical prostatectomy (RARP).
BJU Int. 2013 Mar 7. doi:
10.1111/bju.12001. [Epub ahead of print]
Abstract
| Related
citations
|
|
Gleason
scoring system |
|
Kim KH, Lim SK, Shin TY, Lee JY, Chung BH, Rha KH, Hong SJ.
Upgrading
of Gleason score and prostate volume: a clinicopathological analysis.
BJU Int. 2013 Mar 4. doi:
10.1111/j.1464-410X.2013.11799.x. [Epub ahead of print]
Abstract
| Related
citations
|
|
Pierorazio PM, Walsh PC, Partin AW, Epstein JI.
Prognostic
Gleason grade grouping: data based on the modified Gleason scoring system.
BJU Int. 2013 May;111(5):753-60.
doi: 10.1111/j.1464-410X.2012.11611.x. Epub 2013 Mar 6.
Abstract
| Full
text | Related
citations
|
|
Hyperglycemia |
|
Wright JL, Plymate SR, Porter MP, Gore JL, Lin DW, Hu E, Zeliadt SB.
Hyperglycemia
and prostate cancer recurrence in men treated for localized prostate cancer.
Prostate
Cancer Prostatic Dis. 2013 Mar 5. doi: 10.1038/pcan.2013.5. [Epub
ahead of print]
Abstract
| Related
citations
|
|
Lymph
node dissection |
|
Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N, Fossati N,
Sun M, Dell'oglio P, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F,
Briganti A.
Extended
pelvic lymph node dissection in prostate cancer: a 20-year audit in a single
center.
Ann
Oncol. 2013 Mar 18. [Epub ahead of print]
Abstract
| Related
citations
|
|
Obesity |
|
Tomaszewski JJ, Chen YF, Bertolet M, Ristau BT, Woldemichael E, Nelson JB.
Obesity
is not associated with aggressive pathologic features or biochemical
recurrence after radical prostatectomy.
Urology. 2013 May;81(5):992-7. doi:
10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.
Abstract
| Related
citations
|
|
Risk
and mortality |
|
Bourgade V, Drouin SJ, Yates DR, Parra J, Bitker MO, Cussenot O, Rouprêt M.
Impact
of the length of time between diagnosis and surgical removal of urologic
neoplasms on survival.
World J Urol.
2013 Mar 2. [Epub ahead of print]
Abstract
| Related
citations
|
|
Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope
SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C,
Kattan MW, Kibel AS.
Mortality
After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam
Radiation Therapy, or Brachytherapy in Men Without Comorbidity.
Eur Urol. 2013 Mar 13.
doi:pii: S0302-2838(13)00229-7. 10.1016/j.eururo.2013.03.005. [Epub ahead of
print]
Abstract
| Full
text | Related
citations
|
|
van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers
A, van der Poel HG.
Timing
of Curative Treatment for Prostate Cancer: A Systematic Review.
Eur Urol. 2013 Feb 22.
doi:pii: S0302-2838(13)00136-X. 10.1016/j.eururo.2013.02.024. [Epub ahead of
print]
Abstract
| Related
citations
|
|
RARP |
|
Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR.
How
does robot-assisted radical prostatectomy (RARP) compare with open surgery
in men with high-risk prostate cancer?
BJU Int. 2013 Mar 4. doi:
10.1111/j.1464-410X.2012.11493.x. [Epub ahead of print]
Abstract
| Related
citations
|
ACTIVE SURVEILLANCE
|
|
|
Selvadurai ED, Singhera M, Thomas K, Mohammed K, Woode-Amissah R, Horwich A,
Huddart RA, Dearnaley DP, Parker CC.
Medium-term
Outcomes of Active Surveillance for Localised Prostate Cancer.
Eur Urol. 2013 Feb 18.
doi:pii: S0302-2838(13)00132-2. 10.1016/j.eururo.2013.02.020. [Epub ahead of
print]
Abstract
| Related
citations
|
RECURRENT PROSTATE CANCER
|
|
|
Abdollah F, Boorjian S, Cozzarini C, Suardi N, Sun M, Fiorino C, di Muzio N,
Karakiewicz PI, Montorsi F, Karnes RJ, Briganti A.
Survival
Following Biochemical Recurrence After Radical Prostatectomy and Adjuvant
Radiotherapy in Patients With Prostate Cancer: The Impact of Competing
Causes of Mortality and Patient Stratification.
Eur Urol. 2013 Mar 13.
doi:pii: S0302-2838(13)00230-3. 10.1016/j.eururo.2013.03.006. [Epub ahead of
print]
Abstract
| Related
citations
|
|
Evangelista L, Zattoni F, Guttilla A, Saladini G, Zattoni F, Colletti PM,
Rubello D.
Choline
PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic
Review and Meta-Analysis.
Clin Nucl Med.
2013 May;38(5):305-14. doi: 10.1097/RLU.0b013e3182867f3c.
Abstract
| Related
citations
|
|
García JR, Ponce A, Canales M, Ayuso J, Moragas M, Soler M.
[Detection
of second tumors in 11C-choline PET/CT studies performed due to
biochemical recurrence of prostate cancer.]
Rev
Esp Med Nucl Imagen Mol. 2013 Mar 13. doi:pii: S2253-654X(13)00010-3.
10.1016/j.remn.2013.01.007. [Epub ahead of print] Spanish.
Abstract
| Related
citations
|
|
Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern
DE, Kantoff PW, Taplin ME.
Long-term
follow-up of a phase II trial of chemotherapy plus hormone therapy for
biochemical relapse after definitive local therapy for prostate cancer.
Urology. 2013 Mar;81(3):611-6. doi:
10.1016/j.urology.2012.12.025.
Abstract
| Related
citations
|
|
Schiavina R, Borghesi M, Fiorentino M, Brunocilla E, Manferrari F, Vagnoni
V, Martorana G.
Identification
of prostate cancer risk categories according to surgical margins status,
pathological stage and Gleason score.
Int
J Urol. 2013 Mar 21. doi: 10.1111/iju.12124. [Epub ahead of print]
Abstract
| Related
citations
|
|
Yamamoto S.
Editorial
Comment from Dr Yamamoto to Identification of prostate cancer risk
categories according to surgical margins status, pathological stage and
Gleason score.
Int
J Urol. 2013 Mar 21. doi: 10.1111/iju.12134. [Epub ahead of print]
Abstract
| Full
text | Related
citations
|
|
Yeung VH, Chiu Y, Yu SS, Au WH, Chan SW.
Are
preoperative kattan and stephenson nomograms predicting biochemical
recurrence after radical prostatectomy applicable in the chinese population?
ScientificWorldJournal.
2013;2013:506062. doi: 10.1155/2013/506062. Epub 2013 Mar 5.
Abstract
| Full
text | Related
citations
|
LOCALIZED PROSTATE CANCER
|
|
|
Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim
JS, Lei S, Batipps GP, Kowalczyk K, Bandi G, Pahira J, McGeagh KG, Collins
BT, Krishnan P, Dawson NA, Taylor KL, Dritschilo A, Lynch JH, Collins SP.
Stereotactic
Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the
Georgetown University experience.
Radiat Oncol.
2013 Mar 13;8:58. doi: 10.1186/1748-717X-8-58.
Abstract
| Full
text | Related
citations
|
|
Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C.
Prostate
cancer: how do patients choose their treatment?
Bull Cancer. 2013 Mar
1;100(3):191-199.
Abstract
| Related
citations
|
|
|
Røder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H,
Carlsson S, Jakobsen H, Borre M, Iversen P.
Survival
after radical prostatectomy for clinically localised prostate cancer: a
population-based study.
BJU Int. 2013 Mar 15.
doi: 10.1111/bju.12065. [Epub ahead of print]
Abstract
| Related
citations
|
|
|
|